FT Tech Tonic
FT Tech Tonic
Financial Times
The risks and rewards of gene-editing
29 minutes Posted Jan 16, 2019 at 5:00 am.
0:00
29:57
Download MP3
Show notes
Robin Lovell-Badge, developmental biologist and geneticist, talks to FT science columnist Anjana Ahuja about the gene-edited babies controversy in China and about the potential for new gene-editing techniques to transform the treatment of diseases like cancer and muscular dystrophy.

Hosted on Acast. See acast.com/privacy for more information.